AFT PharmaceuticalsNZSE:AFT +0.54%96 Pretax Margin % is 12.66% as of Mar. 2026, which is 53% above its 10-year median of 8.26. GuruFocus rates NZSE:AFT with a GF Score™ of 96/100 and a GF Value™ of NZ$4.15 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 952 Drug Manufacturers companies, AFT Pharmaceuticals ranks better than 54.2% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
AFT Pharmaceuticals Pretax Margin % Related Terms
AFT Pharmaceuticals Pretax Margin % Historical Data
* Premium members only.
The historical data trend for AFT Pharmaceuticals's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:AFT vs ZTS, UTHR, VTRS: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AFT Pharmaceuticals Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where AFT Pharmaceuticals's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AFT Pharmaceuticals (NZSE:AFT) has a Pretax Margin % of 12.66% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on AFT Pharmaceuticals and its competitors. This is 53% above median its historical median of 8.26. According to the industry distribution chart, AFT Pharmaceuticals ranks #436 out of 952 companies in the Drug Manufacturers industry, placing it in the top 45.8%.
Is AFT Pharmaceuticals' Pretax Margin % too high?
AFT Pharmaceuticals' current Pretax Margin % of 12.66% is 53% above median its 10-year median of 8.26. The Drug Manufacturers industry median Pretax Margin % is 7.30. AFT Pharmaceuticals' value of 12.66% is 73.5% above this industry median. Based on the distribution chart, AFT Pharmaceuticals ranks #436 out of 952 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, AFT Pharmaceuticals has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AFT Pharmaceuticals' Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, AFT Pharmaceuticals ranks #436 out of 952 companies for Pretax Margin %. This puts AFT Pharmaceuticals in the upper half of its industry. The industry median Pretax Margin % is 7.30. AFT Pharmaceuticals' value of 12.66% is 73.5% above this benchmark. While the company's 10-year median is 8.26 vs. the industry median of 7.30, AFT Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AFT Pharmaceuticals's current Pretax Margin % of 12.66% is 73.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on AFT Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AFT Pharmaceuticals's current Pretax Margin % is 12.66%, which is 53% above median its own 10-year median of 8.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AFT Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, AFT Pharmaceuticals (NZSE:AFT) is currently considered Modestly Undervalued. The stock's GF Value™ is NZ$4.15, compared to a current price of NZ$3.70 — trading 10.8% below its estimated fair value. The current Pretax Margin % is 12.66%, which is 53% above median its 10-year median of 8.26 and 73.5% above the Drug Manufacturers industry median of 7.30. AFT Pharmaceuticals' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For AFT Pharmaceuticals (NZSE:AFT), the current Pretax Margin % is 12.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AFT Pharmaceuticals (NZSE:AFT) Overvalued in 2026?
Based on GuruFocus' analysis, AFT Pharmaceuticals stock appears to be undervalued.
The current stock price of NZ$3.70 is trading 10.8% below its estimated GF Value™ of NZ$4.15.
GuruFocus considers AFT Pharmaceuticals to be Modestly Undervalued.
Key valuation signals for NZSE:AFT:
Pretax Margin %: 12.66% (53% above median its 10-year median of 8.26)
GF Value™: NZ$4.15 vs. price of NZ$3.70 (10.8% below fair value)
Industry Position: 73.5% above the Drug Manufacturers median (#436 of 952)
No single metric tells the full story. See the NZSE:AFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Maxigesic dose forms, Capsaicin creams, Crystaderm, Kiwisoothe, Micolette, and others. The group has four operating segments based on geographical location being Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia, which includes the sales and distribution activity relating to the Australian market.
96GF Score
Get the complete analysis for NZSE:AFT
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:AFT has been successfully added to your 
